|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross Profit (Loss) | |||||
| Operating (Income) Expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Selling, general and administrative | |||||
| Asset impairments | |||||
| Realized gain - digital assets | |||||
| Unrealized loss - digital assets | |||||
| Impairment loss - digital assets | |||||
| Impairment loss - other assets | |||||
| Gain on covered call option | |||||
| Provision for credit losses | |||||
| Reacquisition of license rights | |||||
| Net Operating Expenses | |||||
| Loss From Operations | |||||
| Other Income (Expense): | |||||
| Other income (expense), net | |||||
| Gain on extinguishment of liabilities | |||||
| Change in fair value of equity consideration payable | |||||
| Interest expense | |||||
| Interest income | |||||
| Total Other Income (Expense), Net | |||||
| Net Loss | |||||
| Dividend to preferred stockholders | |||||
| Net Loss Attributable to Common Stockholders | |||||
| Net Loss per Share | |||||
| Net Loss per Share - Basic (in dollars per share) | |||||
| Net Loss per Share - Diluted (in dollars per share) | |||||
| Shares Outstanding | |||||
| Shares Outstanding - Basic (in shares) | |||||
| Shares Outstanding - Diluted (in shares) | |||||
Loading...